CompletedPhase 4NCT05750875
Gabapentin Versus Loratadine in Uremic Pruritus
Studying Uremic pruritus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- King Edward Medical University
- Principal Investigator
- Noor-Un-Nisaa Zia, MD MedicineKing Edward Medical University
- Intervention
- Loratadine(drug)
- Enrollment
- 64 target
- Eligibility
- 18-70 years · All sexes
- Timeline
- 2022 – 2022
Study locations (1)
- King Edward Medical University/Mayo Hospital, Lahore, Punjab Province, Pakistan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05750875 on ClinicalTrials.govOther trials for Uremic pruritus
Additional recruiting or active studies for the same condition.